Skip to main content
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.61
-0.70 (-4.89%)
At close: Nov 13, 2026, 4:00 PM EST
13.68
+0.07 (0.51%)
After-hours: Nov 13, 2026, 7:30 PM EST

Korro Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.296.392.27---
Revenue Growth
-82.47%181.46%----
Gross Profit
-41.01-48.74-50.04-48--
Operating Income
-76.12-87.34-91.91-84.53-59-35.49
Net Income
-106.13-117.26-83.58-81.17-58.03-21.96
Earnings Per Share
-7.50-12.48-9.37-53.08-227.42-4.94
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
124.8285.19163.05166.1555.25118.53
Total Debt
41.5243.4944.7733.213.13-
Net Cash (Debt)
83.341.7118.29132.9452.12118.53
Net Cash Growth
44.05%-64.75%-11.02%155.08%-56.03%-
Net Cash Per Share
5.894.4413.2686.93204.2426.65

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-63.71-78.56-60.07-67.28-53.65-32.09
Capital Expenditures
-0.17-0.52-17.9-7.84-5.21-4.45
Free Cash Flow
-63.87-79.08-77.98-75.12-58.86-36.54
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-5891.49%-1366.43%-4047.12%---
Pretax Margin
-8129.41%-1824.52%-3674.15%---
Profit Margin
-8214.47%-1834.48%-3680.36%---
FCF Margin
-4943.81%-1237.16%-3433.55%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
144.5911.80157.04---